α-synuclein Antibodies

Santa Cruz Biotechnology offers a broad range of α-synuclein monoclonal antibodies for investigating neurodegenerative diseases. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). α-Synuclein is a presynaptic protein essential for synaptic function and neurotransmitter release. The aggregation of α-synuclein represents a key characteristic of several neurodegenerative disorders, including Parkinson's disease and dementia with Lewy bodies. Research focused on α-synuclein continues to reveal new insights about disease progression and potential treatments. Scientists worldwide rely on highly specific monoclonal antibodies to examine α-synuclein's role in both healthy and diseased states. Investigating α-synuclein's molecular mechanisms helps identify new therapeutic targets and biomarkers. Current research explores how α-synuclein modifications influence cellular processes and disease development. Santa Cruz Biotechnology monoclonal antibodies for α-synuclein support researchers in advancing scientific understanding of neurodegenerative diseases and potential therapeutic approaches.